SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-055695
Filing Date
2023-10-26
Accepted
2023-10-26 17:22:28
Documents
64
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cbio-20230930.htm   iXBRL 10-Q 2207322
2 EX-31.1 cbio-ex31_1.htm EX-31.1 19603
3 EX-31.2 cbio-ex31_2.htm EX-31.2 19751
4 EX-32.1 cbio-ex32_1.htm EX-32.1 14363
5 EX-32.2 cbio-ex32_2.htm EX-32.2 14369
  Complete submission text file 0000950170-23-055695.txt   7645356

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cbio-20230930_lab.xml EX-101.LAB 441527
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cbio-20230930_def.xml EX-101.DEF 277057
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cbio-20230930.xsd EX-101.SCH 56755
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cbio-20230930_pre.xml EX-101.PRE 357914
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cbio-20230930_cal.xml EX-101.CAL 34450
58 EXTRACTED XBRL INSTANCE DOCUMENT cbio-20230930_htm.xml XML 1126323
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51173 | Film No.: 231351213
SIC: 2834 Pharmaceutical Preparations